Trinity Stock Today

TRIB
 Stock
  

USD 1.36  0.03  2.26%   

Market Performance
8 of 100
Odds Of Distress
Less than 42
Trinity Bio is trading at 1.36 as of the 26th of June 2022, a 2.26 percent increase since the beginning of the trading day. The stock's open price was 1.33. Trinity Bio has about a 42 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Trinity Bio ADR are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 6th of July 2020 and ending today, the 26th of June 2022. Click here to learn more.
CUSIP
896438108
Fiscal Year End
December
Business Domain
Health Care Equipment & Services
IPO Date
18th of August 1995
Category
Healthcare
Classification
Health Care
ISIN
US8964383066
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market in the United States, Africa, Asia, and Europe. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland. The company has 20.9 M outstanding shares of which 413.09 K shares are at this time shorted by private and institutional investors with about 0.25 trading days to cover. More on Trinity Bio ADR

Moving against Trinity Bio

0.78ACBAurora Cannabis Fiscal Year End 26th of September 2022 PairCorr
0.74AFMDAffimed NV Financial Report 7th of July 2022 PairCorr
0.69ACSTAcasti Pharma Financial Report 28th of June 2022 PairCorr
0.57ANGOAngiodynamics Financial Report 12th of July 2022 PairCorr

Trinity Bio Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Trinity Bio's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Trinity Bio or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Trinity Bio ADR may become a speculative penny stock
Trinity Bio ADR has very high historical volatility over the last 90 days
The company currently holds 97.18 M in liabilities. Trinity Bio ADR has a current ratio of 0.71, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Trinity Bio until it has trouble settling it off, either with new capital or with free cash flow. So, Trinity Bio's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Trinity Bio ADR sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Trinity to invest in growth at high rates of return. When we think about Trinity Bio's use of debt, we should always consider it together with cash and equity.
Latest headline from www.defenseworld.net: MAN GRP PLCADR Stock Price Passes Above Two Hundred Day Moving Average of 1.79 - Defense World
ChairmanRonan OCaoimh
Average Analyst Recommendation
Analysts covering Trinity Bio report their recommendations after researching Trinity Bio's financial statements, talking to executives and customers, or listening in on Trinity Bio's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Trinity Bio ADR. The Trinity consensus assessment is calculated by taking the average forecast from all of the analysts covering Trinity Bio.
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Trinity Bio's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Trinity Bio ADR (TRIB) is traded on NASDAQ Exchange in USA and employs 543 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 28.43 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Trinity Bio's market, we take the total number of its shares issued and multiply it by Trinity Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Trinity Bio ADR conducts business under Healthcare sector and is part of Diagnostics & Research industry. The entity has 20.9 M outstanding shares of which 413.09 K shares are at this time shorted by private and institutional investors with about 0.25 trading days to cover. Trinity Bio ADR currently holds about 25.91 M in cash with 11.51 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.24.
Check Trinity Bio Probability Of Bankruptcy
Ownership
Trinity Bio ADR shows a total of twenty million nine hundred thousand outstanding shares. 30% of Trinity Bio ADR outstanding shares are owned by institutional holders. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulation than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or about to change. Please note that no matter how much assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.

Ownership Allocation (%)

Check Trinity Ownership Details

Trinity Stock Price Odds Analysis

What are Trinity Bio's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Trinity Bio jumping above the current price in 90 days from now is about 9.12%. The Trinity Bio ADR probability density function shows the probability of Trinity Bio stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Trinity Bio has a beta of 0.9104. This usually implies Trinity Bio ADR market returns are sensitive to returns on the market. As the market goes up or down, Trinity Bio is expected to follow. Additionally, the company has an alpha of 0.597, implying that it can generate a 0.6 percent excess return over DOW after adjusting for the inherited market risk (beta).
  Odds Below 1.36HorizonTargetOdds Above 1.36
90.82%90 days
 1.36 
9.12%
Based on a normal probability distribution, the odds of Trinity Bio to move above the current price in 90 days from now is about 9.12 (This Trinity Bio ADR probability density function shows the probability of Trinity Stock to fall within a particular range of prices over 90 days) .

Trinity Bio ADR Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Trinity Bio market risk premium is the additional return an investor will receive from holding Trinity Bio long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Trinity Bio. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Trinity Bio's alpha and beta are two of the key measurements used to evaluate Trinity Bio's performance over the market, the standard measures of volatility play an important role as well.

Trinity Stock Against Markets

Picking the right benchmark for Trinity Bio stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Trinity Bio stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Trinity Bio is critical whether you are bullish or bearish towards Trinity Bio ADR at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Trinity Bio without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Volatility Now

   

Portfolio Volatility

Check portfolio volatility and analyze historical return density to properly model market risk
All  Next Launch Module

Trinity Bio Corporate Directors

Trinity Bio corporate directors refer to members of a Trinity Bio board of directors. The board of directors generally takes responsibility for the Trinity Bio's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Trinity Bio's board members must vote for the resolution. The Trinity Bio board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Peter Coyne - Non-Executive Independent DirectorProfile
Denis Burger - Senior Non-Executive Independent DirectorProfile
James Merselis - Non-Executive Independent DirectorProfile
Clinton Severson - Non-Executive DirectorProfile

Investing Trinity Bio ADR

You need to understand the risk of investing before taking a position in Trinity Bio. The danger of trading Trinity Bio ADR is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Trinity Bio is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Trinity Bio. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Trinity Bio ADR is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additionally, take a look at World Market Map. Note that the Trinity Bio ADR information on this page should be used as a complementary analysis to other Trinity Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for Trinity Stock analysis

When running Trinity Bio ADR price analysis, check to measure Trinity Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Trinity Bio is operating at the current time. Most of Trinity Bio's value examination focuses on studying past and present price action to predict the probability of Trinity Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Trinity Bio's price. Additionally, you may evaluate how the addition of Trinity Bio to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Is Trinity Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Trinity Bio. If investors know Trinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Trinity Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.77
Market Capitalization
51.8 M
Quarterly Revenue Growth YOY
-0.31
Return On Assets
0.0446
Return On Equity
-1.91
The market value of Trinity Bio ADR is measured differently than its book value, which is the value of Trinity that is recorded on the company's balance sheet. Investors also form their own opinion of Trinity Bio's value that differs from its market value or its book value, called intrinsic value, which is Trinity Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Trinity Bio's market value can be influenced by many factors that don't directly affect Trinity Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Trinity Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Trinity Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Trinity Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.